These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 18396857

  • 21. Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.
    Sheldon JE, Dcona MM, Lyons CE, Hackett JC, Hartman MC.
    Org Biomol Chem; 2016 Jan 07; 14(1):40-9. PubMed ID: 26503632
    [Abstract] [Full Text] [Related]

  • 22. A new approach to combretastatin D2.
    Cousin D, Mann J, Nieuwenhuyzen M, van den Berg H.
    Org Biomol Chem; 2006 Jan 07; 4(1):54-62. PubMed ID: 16357997
    [Abstract] [Full Text] [Related]

  • 23. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
    Medarde M, Maya AB, Pérez-Melero C.
    J Enzyme Inhib Med Chem; 2004 Dec 07; 19(6):521-40. PubMed ID: 15662956
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
    Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3417-20. PubMed ID: 17434303
    [Abstract] [Full Text] [Related]

  • 25. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M, Greene LM, Knox AJ, Lloyd DG, Zisterer DM, Meegan MJ.
    Eur J Med Chem; 2010 Dec 15; 45(12):5752-66. PubMed ID: 20933304
    [Abstract] [Full Text] [Related]

  • 26. New naphthylcombretastatins. Modifications on the ethylene bridge.
    Sánchez Maya AB, Pérez-Melero C, Salvador N, Peláez R, Caballero E, Medarde M.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2097-107. PubMed ID: 15727863
    [Abstract] [Full Text] [Related]

  • 27. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
    Sriram M, Hall JJ, Grohmann NC, Strecker TE, Wootton T, Franken A, Trawick ML, Pinney KG.
    Bioorg Med Chem; 2008 Sep 01; 16(17):8161-71. PubMed ID: 18722127
    [Abstract] [Full Text] [Related]

  • 28. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
    Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, Lawrence NJ.
    Bioorg Med Chem; 2009 Nov 15; 17(22):7698-710. PubMed ID: 19837593
    [Abstract] [Full Text] [Related]

  • 29. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.
    Simoni D, Romagnoli R, Baruchello R, Rondanin R, Grisolia G, Eleopra M, Rizzi M, Tolomeo M, Giannini G, Alloatti D, Castorina M, Marcellini M, Pisano C.
    J Med Chem; 2008 Oct 09; 51(19):6211-5. PubMed ID: 18783207
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and biological evaluation of 3-(trimethoxyphenyl)-2(3H)-thiazole thiones as combretastatin analogs.
    Banimustafa M, Kheirollahi A, Safavi M, Kabudanian Ardestani S, Aryapour H, Foroumadi A, Emami S.
    Eur J Med Chem; 2013 Oct 09; 70():692-702. PubMed ID: 24219991
    [Abstract] [Full Text] [Related]

  • 31. A novel class of trans-methylpyrazoline analogs of combretastatins: synthesis and in-vitro biological testing.
    Lee M, Brockway O, Dandavati A, Tzou S, Sjoholm R, Satam V, Westbrook C, Mooberry SL, Zeller M, Babu B, Lee M.
    Eur J Med Chem; 2011 Jul 09; 46(7):3099-104. PubMed ID: 21524832
    [Abstract] [Full Text] [Related]

  • 32. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
    O'Boyle NM, Carr M, Greene LM, Bergin O, Nathwani SM, McCabe T, Lloyd DG, Zisterer DM, Meegan MJ.
    J Med Chem; 2010 Dec 23; 53(24):8569-84. PubMed ID: 21080725
    [Abstract] [Full Text] [Related]

  • 33. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
    Liou JP, Chang YL, Kuo FM, Chang CW, Tseng HY, Wang CC, Yang YN, Chang JY, Lee SJ, Hsieh HP.
    J Med Chem; 2004 Aug 12; 47(17):4247-57. PubMed ID: 15293996
    [Abstract] [Full Text] [Related]

  • 34. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
    Nakamura M, Kajita D, Matsumoto Y, Hashimoto Y.
    Bioorg Med Chem; 2013 Dec 01; 21(23):7381-91. PubMed ID: 24139940
    [Abstract] [Full Text] [Related]

  • 35. Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies.
    Kumar B, Sharma P, Gupta VP, Khullar M, Singh S, Dogra N, Kumar V.
    Bioorg Chem; 2018 Aug 01; 78():130-140. PubMed ID: 29554587
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.
    Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez Cara C, Carrion MD, Brancale A, Hamel E, Chen L, Bortolozzi R, Basso G, Viola G.
    J Med Chem; 2010 May 27; 53(10):4248-58. PubMed ID: 20420439
    [Abstract] [Full Text] [Related]

  • 37. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
    Borrel C, Thoret S, Cachet X, Guénard D, Tillequin F, Koch M, Michel S.
    Bioorg Med Chem; 2005 Jun 01; 13(11):3853-64. PubMed ID: 15863010
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.
    Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP.
    J Med Chem; 2004 May 20; 47(11):2897-905. PubMed ID: 15139768
    [Abstract] [Full Text] [Related]

  • 39. Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies.
    Burja B, Cimbora-Zovko T, Tomić S, Jelusić T, Kocevar M, Polanc S, Osmak M.
    Bioorg Med Chem; 2010 Apr 01; 18(7):2375-87. PubMed ID: 20338766
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.
    Arthuis M, Pontikis R, Chabot GG, Seguin J, Quentin L, Bourg S, Morin-Allory L, Florent JC.
    ChemMedChem; 2011 Sep 05; 6(9):1693-705. PubMed ID: 21732536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.